EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TAMs in the Gynecological Tumor Microenvironment: Insights from Cross-Cancer Studies for Immunotherapy

Ruixi Li, Hanyue Liang, Hao Chen, Runjia Weng iD, Quan Ding, Ziqiu Cai, Shirui Wang, Yulin Li iD

Cancers · 25.04.2026 · 18 (9) · 1372

DOI: 10.3390/cancers18091372 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.04.2026. Verfasst von Ruixi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Main Campus, Chengdu University of Traditional Chinese Medicine, Chengdu 610032, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) play a central role in tumor progression and therapeutic resistance in gynecological malignancies, including ovarian cancer (OC), cervical cancer (CC), and endometrial cancer (EC). This review systematically summarizes common regulatory mechanisms and tumor-specific variations in TAMs across these three malignancies, emphasizing the dual-origin developmental trajectories of tissue-resident macrophages and monocyte-derived macrophages, the CCL2-CCR2 and CSF1-CSF1R core signaling axes, and the regulation of TAMs’ functional polarization by hypoxia and metabolic reprogramming. Furthermore, the molecular mechanisms through which TAMs mediate immunosuppression and therapeutic resistance via physical barrier construction, metabolic competition, and antigen presentation impairment are analyzed, and the specific characteristics of the peritoneal microenvironment in OC, HPV-driven mechanisms in CC, and hormonal regulation in EC are compared. Therapeutic strategies targeting TAM recruitment, survival, and phenotypic reprogramming are discussed, along with TAM markers, and may provide a theoretical foundation and clinical indications for overcoming immune therapeutic resistance in gynecological malignancies.

Schlagwörter

Stichwörter der Autor:innen

gynecological cancersimmunosuppressiontargeted therapytherapeutic resistancetumor microenvironmenttumor-associated macrophages

Autor:innen und Institutionen

  • Main Campus, Chengdu University of Traditional Chinese Medicine, Chengdu 610032, China.
  • School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • School of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
  • School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

ORCID-Profile: Runjia Weng, Yulin Li

Förderung

  • Chengdu University of Traditional Chinese Medicine

Zitieren

APA

Li, R., Liang, H., Chen, H., Weng, R., Ding, Q., Cai, Z., Wang, S., & Li, Y. (2026). TAMs in the Gynecological Tumor Microenvironment: Insights from Cross-Cancer Studies for Immunotherapy. Cancers, 18(9), 1372. https://doi.org/10.3390/cancers18091372

Vancouver

Li R, Liang H, Chen H, Weng R, Ding Q, Cai Z, et al. TAMs in the Gynecological Tumor Microenvironment: Insights from Cross-Cancer Studies for Immunotherapy. Cancers. 2026;18(9):1372. doi:10.3390/cancers18091372

BibTeX
@article{Li2026,
  author = {Li, Ruixi and Liang, Hanyue and Chen, Hao and Weng, Runjia and Ding, Quan and Cai, Ziqiu and Wang, Shirui and Li, Yulin},
  title = {TAMs in the Gynecological Tumor Microenvironment: Insights from Cross-Cancer Studies for Immunotherapy},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1372},
  doi = {10.3390/cancers18091372}
}
Kostenlos starten →